Loading...
XSWX
DOCM
Market cap323mUSD
Dec 05, Last price  
5.36CHF
1D
-1.65%
1Q
-15.46%
IPO
-96.43%
Name

Zur Rose Group AG

Chart & Performance

D1W1MN
XSWX:DOCM chart
P/E
—
P/S
0.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
6.36%
Rev. gr., 5y
-5.58%
Revenues
1.02b
+4.91%
488,269,000487,192,000523,306,000910,609,000915,554,000834,418,000879,535,000982,921,0001,207,108,0001,355,539,0001,476,930,0001,726,503,0001,608,222,000969,462,0001,017,045,000
Net income
-97m
L
3,921,0008,674,0006,156,000-15,464,0007,154,0003,445,000-12,769,000-36,238,000-38,971,000-52,358,000-135,695,000-225,735,000-171,115,00082,280,000-97,253,000
CFO
-27m
L-69.57%
13,960,0002,806,00020,809,0002,004,0007,200,00018,872,000-13,830,000-22,227,000-33,227,000-82,571,000-67,511,000-130,631,000-97,287,000-87,415,000-26,598,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
URL
https://www.zurrosegroup.com/
IPO date
Jul 06, 2017
Employees
2,283
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT